Replies to post #3175 on GTC Biotherapeutics (fka GTCB)

[biopearl]

Dew, In last conference call Dr. Cox alluded to slow enrollment in US study, do remember this? I suspect we will see delays in the timeline outlined...bp

[DewDiligence]

U.S. ATryn Development Timeline for HD Indication

[These expectations are based on the slightly-updated guidance in today’s press release (#msg-19329705).]

3Q07: Complete enrollment
4Q07: Report clinical results
Early 2008: Submit BLA
Late 2008/early 2009: FDA decision on BLA